Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Basmisanil (RG1662) is a negative allosteric modulator/inverse agonist of GABAAα5 receptors.Formulations containing basmisanil are in clinical trials for the treatment of cognitive impairments associated with Down syndrome.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
2 mg | 在庫あり | ¥ 7,500 | |||
5 mg | 在庫あり | ¥ 12,000 | |||
10 mg | 在庫あり | ¥ 16,500 | |||
25 mg | 在庫あり | ¥ 29,000 | |||
50 mg | 在庫あり | ¥ 47,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,000 |
説明 | Basmisanil (RG1662) is a negative allosteric modulator/inverse agonist of GABAAα5 receptors.Formulations containing basmisanil are in clinical trials for the treatment of cognitive impairments associated with Down syndrome. |
別名 | RG1662, RO5186582 |
分子量 | 445.46 |
分子式 | C21H20FN3O5S |
CAS No. | 1159600-41-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL (71.84 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Basmisanil 1159600-41-5 Membrane transporter/Ion channel Neuroscience GABA Receptor α subunit-containing GABAA receptors (GABAAα5) psychiatric disorders RG1662 negative allosteric modulator (NAMs) γ-Aminobutyric acid Receptor cognitive Inhibitor RG-1662 Gamma-aminobutyric acid Receptor RO 5186582 RO5186582 RG 1662 inhibit RO-5186582 inhibitor